Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

scientific article published on July 2004

Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.BBMT.2003.12.004
P698PubMed publication ID15205665

P50authorDon J. DiamondQ37374385
Simon F LaceyQ56978267
P2093author name stringJohn A Zaia
P433issue7
P921main subjectCytomegalovirusQ6946
P304page(s)433-447
P577publication date2004-07-01
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleAssessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants
P478volume10

Reverse relations

cites work (P2860)
Q37213897Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal
Q34104346CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults
Q47111092Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance
Q92446001Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
Q37559627Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation
Q35613340Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation
Q53660426Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation.
Q53557075Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.
Q37237427How we treat cytomegalovirus in hematopoietic cell transplant recipients
Q35965038Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.
Q50551600Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.
Q28072627Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Q35958223Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia
Q37159243Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity
Q36043642Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence
Q36612933Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection
Q37888687Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation
Q42220503Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8⁺ T cells in allogeneic stem-cell transplant recipients
Q36190463Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes
Q40202358Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence
Q36099296Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response
Q55025898The Detailed Kinetics of Cytomegalovirus-specific T cell Responses after Hematopoietic Stem Cell Transplantation: 1 Year Follow-up Data.
Q37460362The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
Q36839736Vaccine strategies against human cytomegalovirus infection.

Search more.